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LIST OF ABBREVIATIONS 
 
HCC = Hepatocellular Carcinoma 
DWI = Diffusion-Weighted Imaging 
MRI = Magnetic Resonance Imaging 
CT = Computed Tomography 
ADC = Apparent Diffusion Coefficient 
ROI = Region of Interest 
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ABSTRACT 
 
Purpose: To assess the relevance of diffusion-weighted imaging (DWI) in the 
hepatocellular carcinoma (HCC) detection as a stand-alone procedure or in combination to 
conventional magnetic resonance imaging (MRI). 
 
Methods: Medical records from nineteen patients with pathological confirmation of 
HCC, who have been submitted to conventional MRI and DWI in a time frame 3 months prior 
and 3 months after diagnosis, were retrospectively reviewed. For each patient, apparent 
diffusion coefficient (ADC) values were measured in the HCC lesion, in the liver parenchyma 
and in the spleen. Tumor ADC and parenchyma ADC, obtained with and without 
normalization, were compared through paired-samples t-test. Tumor ADC was analyzed 
according to lobe, size category and acquisition system using the Mann-Whitney test. For 
sensitivity assessment of DWI and conventional MRI, individually and combined, a 
contingency table was made.  
 
Results: The calculated DWI sensitivity for HCC detection (47.4%) was lower than 
conventional MRI sensitivity (68.4%). The highest sensitivity was obtained with the 
combined reading of both techniques (78.9%).  
A statistically significant difference between tumor ADC and parenchymal ADC was 
found, both for normalized and non-normalized values, with lower values for the HCC 
lesions.  
Comparison of tumor ADC values according to lobe, size and acquisition system did 
not show a statistically significant difference. 
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Conclusions: For HCC detection in the setting of liver cirrhosis the use of DWI 
increases tumor detection compared to conventional MR alone and its use is recommended. 
This result corroborates other literature reports regarding the added value of DWI in HCC 
diagnosis, irrespective of the magnetic field strength. Due to the small patient sample of the 
current series further investigation may be warranted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: hepatocellular carcinoma; diagnosis; magnetic resonance imaging; diffusion 
weighted imaging; apparent diffusion coefficient  
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RESUMO 
 
Objectivo: Determinar a relevância da ressonância magnética ponderada em difusão 
(DWI) no diagnóstico do carcinoma hepatocelular (CHC) a título individual e enquanto 
complemento à ressonância magnética (RM) convencional. 
 
Métodos: Registos médicos de dezanove pacientes com confirmação 
anatomopatológica de CHC, que tinham sido submetidos a RM convencional e DWI na faixa 
temporal 3 meses antes e 3 meses depois do diagnóstico, foram revistos retrospectivamente. 
Para cada paciente foram medidos os valores do coeficiente de difusão aparente 
(ADC) na lesão tumoral, no parênquima hepático e no baço. O ADC do tumor e o ADC do 
parênquima, com e sem normalização, foram comparados através do t-teste para amostras 
emparelhadas e o ADC do tumor foi analisado de acordo com lobo, categoria dimensional e 
sistema de aquisição utilizando o teste de Mann-Whitney. Para determinação da sensibilidade 
da DWI e da RM convencional, individualmente e em conjunto, foi feita uma tabela de 
contingência. 
 
Resultados: A sensibilidade calculada da DWI (47.4%) foi inferior à da RM 
convencional (68.4%). Contudo, a sensibilidade calculada quando ambos os métodos foram 
combinados (78.9%) revelou-se superior. 
Foi encontrada uma diferença estatisticamente significativa entre o ADC do tumor e o 
ADC do parênquima hepático, tanto para os valores não normalizados como para os 
normalizados, com valores menores registados para as lesões tumorais. 
Após comparação dos ADC tumorais de acordo com lobo, categoria dimensional e 
sistema de aquisição, não foi encontrada uma diferença estatisticamente significativa. 
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Conclusões: Os resultados do nosso estudo estão em concordância com a literatura 
mais recente que sustenta o valor adicional da DWI no diagnóstico do CHC. No entanto, as 
limitações que reconhecemos ao presente trabalho sugerem a necessidade de mais 
investigação nesta área. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palavras-Chave: carcinoma hepatocelular; diagnóstico; ressonância magnética; difusão; 
coeficiente de difusão aparente 
7 
 
INTRODUCTION 
 
Hepatocellular carcinoma (HCC) is the sixth most common cancer
1,2
 and the most 
common primary liver malignancy.
1,3,4
 It is also the third cause of cancer-related death and a 
major health problem worldwide due to high rates of morbi-mortality, increasing incidence 
and limited curative treatment options.
2,4,5
 
The probability of occurrence is higher in older male patients, with a peak around 70 
years old. In most of the cases there are known risk factors such as cirrhosis, which may be 
caused by chronic viral hepatitis (B or C), alcohol, alcoholic or non-alcoholic steato-hepatitis 
(CASH and NASH) or inherited metabolic diseases such as hemochromatosis or alfa-1-
antitrypsin deficiency. 
High risk patients should be submitted to abdominal ultrasound surveillance with a 6-
month periodicity.
6
 The diagnosis can be made based on pathology or on non-invasive 
criteria, such as imaging hemodynamic features (arterial enhancement and delayed washout) 
detected per use of computed tomography (CT) or magnetic resonance imaging (MRI). 
Surgery remains the most effective treatment and the only potentially curative 
modality;
5
 however, many patients do not fulfill the stringent criteria for that option at the 
time of the diagnosis. Improvement in liver imaging is therefore needed. 
Diffusion-weighted magnetic resonance imaging (DWI) is a functional MRI technique 
that provides image contrast based on differences in the motion of water molecules within 
tissues, that are affected by intrinsec properties (tissue cell organization, density, 
microstructure and microcirculation). DWI explores the random motion of water molecules in 
the body driven by their internal thermal energy, known as Brownian motion.
7,8
  
DWI, based on a echo-planar T2-weighted sequence, applies 2 additional (motion-
sensitizing) gradients, a dephasing gradient and rephasing gradient, which is known as the 
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Stejskal-Tanner sequence.
9,10
 Tissues with low cellularity allow the free movement of water 
molecules between the gradient application, causing phase dispersion and a reduction in 
signal intensity. Tissues with high cellularity will restrict the water molecules diffusion and 
therefore will show a high sustained signal intensity.
4,7,9,11
 
The sensitivity of a DWI sequence for lesion detection and characterization depends 
mostly on the programmed b-values (s/mm
2
);  at least 2 b-values must be obtained in order to 
perform this technique.
7
 
The mean value of diffusion due to the movement of intracellular, extracellular and 
vascular water molecules within an image voxel at different b-values is called apparent 
diffusion coefficient (ADC, expressed in mm
2
/s), the quantitative expression of DWI. ADC 
maps provide a physiologic estimate of water velocity within a certain tissue and so provides 
an indirect measure of cellularity; the ADC map, through selection of regions of interest 
(ROIs), allows the direct measurement of ADC values thus providing quantitative data.
12
 
Originally used for the evaluation of intracranial diseases, DWI is expanding and is 
being applied in several abdominal applications and whole-body MRI.
7–12
 There are several 
studies showing the potential utilization of DWI for HCC diagnosis, characterization and 
treatment response evaluation; 
3,7,11,13,14 
 most authors agree that it may represent a valuable 
tool, particularly if associated with conventional MRI. 
DWI application to liver lesions study is relatively recent and promising; therefore, it 
is important to address the subject and study its impact in the setting of liver cirrhosis and 
HCC detection. 
Thus the aim of the present work is to assess the relevance of DWI for HCC diagnosis, 
both as an isolated technique or combined to the conventional MRI protocol. 
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MATERIALS AND METHODS 
 
Study population 
This retrospective study enrolled a population selected from a pool of patients with 
histopathological confirmation of hepatocellular carcinoma, used as the gold standard. 
The initial group included patients from 11.09.2008 to 11.09.2014 whose pathological 
report included the expression “hepatocellular carcinoma”. From this pool, n=30 were 
selected by reviewing the type of imaging procedures applied and cross-linking of the 
pathological information with the Radiology Department records. The inclusion criteria were: 
(a) an MR examination containing both conventional MRI and DWI technique, (b) imaging 
procedures applied at the same imaging session and (c) examinations performed within a time 
frame of 3 months prior and 3 months after obtaining the histopathological sample that led to 
HCC diagnosis. 
The medical records of patients were requested to the hospital’s archive to further 
analyse the clinical context and verify the inclusion criteria. In this process 11 patients were 
excluded due to: (a) previous treatment modalities susceptible of altering the results of image 
analysis (n=5); (b) use of the expression “hepatocellular carcinoma” in the pathological report 
out of the intend context (n=5) and (c) lack of data relevant to the study (n=1). 
The final study group consisted of 19 patients and included 16 males and 3 females 
with pathological confirmation of unifocal (n=12) or multifocal (n=7) HCC through biopsy 
(n=6) or resection specimen analysis (n=13). The mean age at diagnosis was 64 years, ranging 
from46 to 76 years. In this population, 16 were cirrhotic and from those, 5 had a history of 
alcohol abuse, 6 had HBV and 3 had HCV. 
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MRI 
The MR images included in this study were obtained using a 1.5T system (n=16) or a 
3T system (n=3). The b-values used in the DWI study obtained with the 1.5T system 
(Magnetom Symphony; Siemens) were b=50 and b=700 and the b-values used in the MRI 
from the 3T system (Magnetom Trio, a Tim System; Siemens) were b=100 and b=800 s/mm
2
. 
 
Image analysis 
MR images were analyzed with the 3D Slicer 4.4.0, an open source software platform 
for the analysis and visualization of medical imaging, intended for research purposes. The 
different MR sequences were reviewed - T1-w, T2-w, dynamic contrast-enhanced study 
(arterial, portal and delayed phase) and DWI – being the ADC values measured in the 
corresponding ADC map. 
In cases of multifocal tumors, only a single representative nodule was selected per 
patient; in cases of unifocal HCC, that selection was made by default. 
In order to measure the ADC values of the HCC lesion, of the surrounding 
parenchyma and of the spleen, the following method was adopted: (a) 3 circular ROIs were 
placed in each one of the above mentioned areas, totalizing 9 ROIs per image; (b) each 
circular ROI had a 5 mm radius; (c) the measurements were performed in the ADC map 
overlaying the DWI images fused and matched with a morphological sequence from another 
MRI sequence to serve as anatomical reference; (d) vessels were excluded and (e) the ROI 
placement on the tumor was deposited in the areas visually more hypointense and 
homogeneous excluding necrosis and/or hemorrhage (Fig.1). 
To allow sensitivity determination of conventional MRI, of DWI and of both 
techniques combined, some criteria was previously defined. On conventional MRI a tumor 
was considered to be detected if: (a) arterial enhancement was present and (b) wash-out was 
11 
 
observed. Regarding DWI, a nodule was considered to represent HCC if (a) lesion ADC < 
surrounding parenchyma ADC, (b) hiperintensity of the lesion at high b-value and (c) hipo or 
isointensity in the ADC map (Fig.2). Two observers performed the readings concurrently and 
discrepancies were solved by consensus. 
12 
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Statistical analysis 
The statistical analysis was performed using SPSS Software (version 20, SPSS). 
Descriptive statistics for each variable were available and visual support of the 
information was also provided (boxplot graphs). To determine the sensitivity of conventional 
MRI, of DWI and of both methods combined, a contingency table was created. 
In order to compare the tumor ADC with the parenchyma ADC, a paired-samples t-
test was used. To compare tumor ADC according to lobe, size category and acquisition 
system non-parametric tests for 2 independent samples - Mann-Whitney test - were 
performed. For each test a P value of <0.05 was considered to represent a statistically 
significant difference. 
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RESULTS 
 
From the n=19 patients of this study, n=13 were correctly diagnosed by conventional 
MRI, n=9 were identified by DWI and n=15 were detected by both methods combined; this 
results in a sensitivity of 68.4% for conventional MRI, 47.4% for DWI and 78.9% for a 
combination of both techniques. The summarized results can be seen in Table 1. 
The mean ADC values (x10
-3
 mm
2
/s) obtained were: 1.159±0.032 for HCC lesions; 
1.242±0.037 for the surrounding parenchyma; 0.815±0.018 for the spleen. The mean ADC 
values after normalization (Liver ADC / Spleen ADC) were 1.445±0.053 for the tumor lesions 
and 1.549±0.053 for the nearby parenchyma. The ADC measurements and results of the 
statistical analysis can be found in Table 2. 
The results from the comparison of tumor ADC according to lobar location, largest 
diameter and magnetic field intensity are summarized in Table 3 and illustrated in Figure 3. 
Regarding pathological differentiation of tumors, it was found that: n=1 had a well-
differentiated tumor (G1), n=15 had a moderately-differentiated tumor (G2), n=1 had a 
moderately-undifferentiated tumor (G3) and n=1 had an undifferentiated tumor (G4). 
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Table 1 Comparison between Conventional MRI and DWI. 
 
          
  
Conventional 
MRI 
DWI 
Conventional 
MRI + DWI             
 
 +  +  + 
      
 
 +  -  + 
      
 
 +  +  + 
      
 
 +  -  + 
      
 
 -  -  - 
 
 
  
Conventional 
MRI  
 
 +  +  + 
 
 
n=19  +  - Total: 
 
 -  -  - 
 
DWI 
 + n=7 n=2 n=9 
 
 +  -  + 
 
 - n=6 n=4 n=10 
 
 +  +  + 
 
 
Total: n=13 n=6 
 
 
 +  +  + 
 
     
 
 +  -  + 
 
 Sensitivity (Conventional MRI) =68.4% 
 
 +  +  + 
 
 Sensitivity (DWI) =47.4%  
 
 -  +  + 
 
 Sensitivity (Conventional MRI +  DWI) =78.9% 
 
 -  +  + 
      
 
 +  +  + 
      
 
 -  -  - 
      
 
 +  -  + 
      
 
 -  -  - 
         +  -  +             
 
n=13 n=9 n=15 
      
Table 2 Tumor ADC vs Parenchyma ADC. 
  
      
    
Mean ADC 
(x10
-3
 mm
2
/s) 
P-value 
Liver ADC / 
Spleen ADC  
P-value 
  
Mean ± SEM 
 
Mean ± SEM  
 
      
HCC (n=19) 1.159±0.032 
0.040 
1.445±0.053 
0.045 
Parenchyma (n=19) 1.242±0.037 1.549±0.053 
SEM: Standard Error of the Mean    
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Table 3 Comparison of tumor ADC according to different variables. 
       
    
Mean tumor ADC 
(x10
-3
 mm
2
/s) 
P-value   
Mean tumor ADC / 
Spleen ADC  
P-value 
 Mean ± SEM   Mean ± SEM  
      
Lobe 
 
0.486 
  
0.336 
 Right lobe (n=13) 1.139±0.032   
1.396±0.053 
 
  Left lobe (n=5) 1.201±0.097     1.545±0.147   
Largest diameter 
 
0.745 
  
0.327 
 ≤2 cm (n=2) 1.133±0.063   
1.279±0.112 
 
  >2 cm (n=16) 1.156±0.038     1.470±0.061   
Acquisition system 
 
0.291 
  
0.359 
 1.5T; b-values=50;700 (n=16) 1.177±0.035   
1.473±0.061 
 
 3T; b-values=100;800 (n=3) 1.065±0.069   
1.292±0.004 
 
SEM: Standard Error of the Mean     
17 
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DISCUSSION 
 
The sensitivity of conventional MRI for HCC diagnosis calculated in this study 
(68.4%) was superior to the sensitivity of DWI as a stand-alone procedure (47.4%); however, 
it was verified that the sensitivity of both techniques combined (78.9%) was better than the 
sensitivity provided by conventional MRI alone. This results suggest the additional value of 
DWI for the HCC diagnosis, a finding that is in line with previous results published in the 
literature.
7,14–17
 
The mean ADC values (x10
-3
 mm
2
/s) obtained in this study (1.159±0.032 for HCC 
lesions, 1.242±0.037 for the surrounding parenchyma and 0.815±0.018 for the spleen) are also 
in line with the ADC values reported concerning DWI application in HCC diagnosis.
13,18,19
 
The mean tumor ADC was lower than the mean parenchyma ADC (both for non-
normalized and for normalized values) providing a quantitative evidence of restriction in DWI 
in HCC lesions. The difference in mean tumor ADC to the liver parenchyma was statistically 
significant (p<0.05), both for absolute (p=0.040) and normalized measurements (p=0.045). 
Our results corroborate the evidence that DWI is a valuable additional technique for 
the diagnosis of HCC; the technique constitutes a non-invasive method that requires no 
contrast media administration,
20
 no extra experts and minimal additional scan time
4
 so it can 
be incorporated in routine protocols. For HCC detection and characterization, while 
conventional MRI focus mostly on tumor neovascularization, DWI evaluates mainly the 
tumor increased cellular density;
11
 the assessment of both is thus additive and may improve 
the chance of early HCC diagnosis and subsequent decision for earlier curative treatment 
options. 
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Kele et al.
7
 stated that quantitative DWI proved to be helpful in characterization of 
focal livers lesions such as HCC, but also stated that it should always be used in combination 
to conventional MRI due the expressive overlap between ADC measurements of benign and 
malignant lesions. Lim et al.
 11
 advocated that the high efficacy of DWI in diagnosing HCC in 
cirrhotic patients justifies its inclusion in routine MR protocols. Nevertheless, worldwide 
standardization of the DWI technique regarding not only the b values but many other 
parameters is currently lacking, and thus investigation about the real role of DWI in the 
context of tumor characterization and prediction of treatment response still waits to gain 
worldwide acceptance. 
The present study retrospectively analyzed cases from two different magnetic field 
systems: one of 1.5T using b-values=50 and 700; the other of 3T using and b-values=100 and 
800 s/mm
2
. This range of b-values is within the range of values previous described for liver 
DWI application and ADC measurements. There was no statistically significant difference 
among them, neither in terms of absolute ADC measurements (p=0.291) or normalized values 
(p=0.359). However, only n=3 patients had images acquired from the 3T system (b-
values=100; 800), which hampers the relevance of the comparison. To better understand the 
influence of the technical parameters of DWI on lesion detection, a larger population should 
be targeted and only one variable at a time should be different - for example, to compare 1.5T 
with a 3T system, the b-values should have been identical. In spite of the absence of 
significant difference between magnets in the present study, it is known that the use of 
different technical parameters and b-values may explain some of the discrepancies in ADC 
measurements reported in the literature 
21
 - lower b-values may lead to overestimation of the 
ADC value, due to the contamination of microperfusion to the diffusion component; on the 
contrary, higher b-values may induce ADC underestimation, due to the increased contribution 
from the low ADC components and progressive reduction of the signal-to-noise ratio.
7
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Currently there is no clear consensus of which b-value should be used to optimally screen the 
liver for HCC detection. This factor together with the absence of other DWI parameter 
standardization 
11
 makes comparisons difficult and creates uncertainty limiting 
reproducibility.
8–12,14,19
  The attempt to normalize the ADC values using an internal reference 
is that it remains relatively constant across systems or patients and thus contribute to reduce 
the  variability in ADC measurement;
21,20
 the spleen seems an adequate choice for signal 
intensity normalization, since it maintains a relatively stable ADC value even in case of liver 
disease. In this study, normalization was obtained through the ratio of liver ADC to spleen 
ADC. When comparing variables, the results did not differ significantly; therefore, the same 
conclusions can be applied after normalization, but with increased reproducibility that may 
allow a better study comparison. 
Several publications
17,18,22
 emphasize the additional DWI value to MR for the 
detection of small HCC lesions, both qualitatively and quantitatively. Kele et al.
7
 reported that 
DWI is useful for the detection of small HCC in cirrhotic liver and that the technique has a 
higher sensitivity, specificity and positive predictive value compared to conventional MRI; 
the explanation included a better lesion to liver contrast as well the effect of background 
signal suppression from bile ducts and vessels. Di Martino et al.
18
, however, reported no 
significant improvement in diagnostic accuracy of small HCC. 
In a recent review article, Lim
11
 emphasized a less consistent efficacy of conventional 
MRI for detecting early HCC (≤2 cm) when compared to larger tumors. This is attributable to 
the less well developed angiogenesis and sinusoidal capilarization seen in small HCC cases 
compared to larger tumors. Also the parenchymal distortion related to fibrosis and the 
background of regenerative nodules poses additional problems for HCC recognition. 
In this study, no statistically significant difference was found between the ≤ 2 cm HCC 
and the >2 cm HCC, both in non-normalized (p=0.745) and in normalized (p=0.327) ADC 
21 
 
measures. As in this study only 2 patients had small HCC ≤2cm, no conclusions can be 
however derived. 
Recent studies
4,21–25
 point out towards a correlation between the degree of HCC 
differentiation and ADC values, with lower ADC values registered in poorly-differentiated 
tumors and higher ADC values in the well-differentiated tumors; the potential for the 
individual prediction of tumor histological grade remains a discussion subject, with some 
authors presenting high expectations while others express concerns related to inter-observer 
variations, lack of standardized procedures and ADC overlap between different tumor 
grades.
27,28
 The existence of such a non-invasive information would certainly contribute to a 
better patient management in terms of treatment choice and prognostic information;
29
 
however, in the present study this factor could not be appreciated due to the low 
interchangeability in tumor grading of the study population. 
According to literature, some limitations for the DWI detection of HCC in the left 
liver lobe could be expected 
7,13,15
 due to motion and pulsation artifacts arising from the heart, 
stomach and bowel with tumors located immediately below the diaphragm more prone to 
escape identification. In the present work, nevertheless, no statistically significant difference 
(p<0.05) could be found between tumors located at the left or right liver lobe in terms of mean 
ADC measurements both before (p=0.486) or after signal intensity normalization (p=0.336). 
We do however believe that the small sample size may not allow to derive firm conclusions 
concerning this particular aspect. 
Our study included only patients whose MRI was assessed no longer than 3 months 
apart from the pathological confirmation of HCC. Given that the mean volume doubling time 
of the tumor ranges from 112 to 204 days,
30
 the chosen interval seems to be appropriate. 
There is, however, a great variability of growth patterns and ideally the MR study should been 
obtain as close as possible to the pathological validation of the resected specimen. 
22 
 
This study has several limitations. The reduced number of patients narrows the 
chances of sustainable correlations. In fact, an increased number of patients has to be included 
in order to better understand the influence of each variable of the DWI technique. The 
retrospective type of analysis may also create a selection bias potentially overestimating the 
accuracy of the technique. Since all selected patients had a positive diagnosis of HCC 
(generating only “true positives” or “false negatives”), it was only possible to determine the 
sensitivity of the methods – their ability to correctly classify an individual as “diseased” - 
individually and combined. To fully analyze the radiologic contribute of the MR techniques 
under discussion, a group of “ true negatives” will also need to be included in order to allow 
calculations of specificity, positive predictive value and negative predictive values.
31
 A 
possible future approach to this issue could be a radiologic analysis consisting of patients 
submitted to liver transplantation where the pathological study of the all liver specimen is 
available; recognition of HCC tumors in the explanted liver not seen in conventional MR 
and/or DWI would also be contributive for the analysis of the techniques.  
In conclusion, and despite the above mentioned limitations, we do believe that the 
present study provides evidence to incorporate the DWI technique in the daily MR practice 
for the study of HCC in the cirrhotic population. 
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CONCLUSION 
 
The sensitivity of conventional MRI determined in this study was superior to the 
sensitivity of DWI; however, the calculated sensitivity of the combined reading of 
conventional MRI and DWI was superior, supporting the routine acquisition of DWI for HCC 
diagnosis. The major shortcomings are due to the lack of standardization of the DWI 
technique precluding a generalized assumption of its real clinical impact for the study of 
cirrhotic patients. 
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